Less than one-third of these patients had evidence of celiac serology results in the medical record, and even in patients with pre-biopsy testing the majority were serologically negative (Table 1).

Given the high sensitivity and specificity of serologic testing, one would expect to find a fairly high diagnostic yield in duodenal biopsies for celiac disease. In a population with a disease ...

The highest sensitivity (95.2%) of celiac disease detection in DM1 children was found in the case of serologic test detecting anti-tTG (IgA tTG), whereas the lowest sensitivity characterized test ...

Background. A 62-year-old postmenopausal woman with a family history of breast cancer, mild gastroesophageal reflux disease, iron-deficient anemia and declining BMD was seen in a specialist center ...

The gold standard for definitive diagnosis of celiac disease is positive serology for IgA anti-tissue transglutaminase (tTG) and IgA endomysial antibodies in the duodenal plan. Untreated celiac ...

Celiac artery compression syndrome, also known as median arcuate ligament syndrome, is a condition where a muscular fibrous band of the diaphragm, the median arcuate ligament, compresses the celiac ...

In adults, the most common symptoms of celiac disease are stomach problems, like gas and diarrhea. A tissue transglutaminase IgA test, or tTg-IgA test, is an effective method used in the diagnosis ...

(reference e5 in our article), after evidence-based evaluation of 2510 studies of the diagnostic potential of celiac serology testing. Current (prospective) studies are investigating this ...

A new study published in Gastroenterology has revealed new findings that could help lead to a cure for celiac disease.

Such kit products comprise SARS-CoV-2 antibody titer serologic assay kits, inhibitor screening kits, antigen pre-coated plates and antigen detection kits. These products can be utilized for SARS ...

Patients can present with fatigue, itching, jaundice or fevers. There is no specific serology test for PSC. Diagnosis is suggested by abnormal imaging tests such as ultrasounds or magnetic resonance ...

BOCA RATON, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (First Wave BioPharma or the Company), a clinical-stage biopharmaceutical company ...